These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ankylosing spondylitis and rheumatoid arthritis in a patient with Paget's disease. Differential effects of indomethacin, D-penicillamine, or gold sodium thiomalate in the respective arthritides. Alarcón-Segovia D; Martínez-Cordero E Arch Intern Med; 1985 Oct; 145(10):1915-7. PubMed ID: 3929708 [TBL] [Abstract][Full Text] [Related]
23. Drug treatment of arthritis in the elderly. Mowat AG Age Ageing; 1979; Suppl():14-25. PubMed ID: 316644 [No Abstract] [Full Text] [Related]
24. Drugs for rheumatoid arthritis. Med Lett Drugs Ther; 1989 Jun; 31(795):61-4. PubMed ID: 2567489 [No Abstract] [Full Text] [Related]
25. The place of levamisole in the armamentarium for rheumatoid arthritis. Huskisson EC J Rheumatol Suppl; 1978; 4():149-52. PubMed ID: 282445 [TBL] [Abstract][Full Text] [Related]
30. Some aspects of slow-acting drugs in rheumatoid arthritis. Ansell BM Agents Actions Suppl; 1979; (5):111-9. PubMed ID: 294130 [No Abstract] [Full Text] [Related]
31. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Luqmani R; Hennell S; Estrach C; Basher D; Birrell F; Bosworth A; Burke F; Callaghan C; Candal-Couto J; Fokke C; Goodson N; Homer D; Jackman J; Jeffreson P; Oliver S; Reed M; Sanz L; Stableford Z; Taylor P; Todd N; Warburton L; Washbrook C; Wilkinson M; ; Rheumatology (Oxford); 2009 Apr; 48(4):436-9. PubMed ID: 19174570 [No Abstract] [Full Text] [Related]
33. [Aspects of differential balneotherapy in rheumatic diseases]. Callies R Z Physiother; 1971; 23(6):397-409. PubMed ID: 5316938 [No Abstract] [Full Text] [Related]
34. [Value of HL-A groups in diagnosis in rheumatology]. Seignalet J; Sany J; Serre H Rev Rhum Mal Osteoartic; 1975 Feb; 42(2):75-83. PubMed ID: 1079368 [TBL] [Abstract][Full Text] [Related]
35. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance]. Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852 [TBL] [Abstract][Full Text] [Related]
36. Methodology issues in the evaluation of NSAID in inflammatory rheumatic diseases. Lequesne M J Rheumatol Suppl; 1990 Feb; 20():25-8. PubMed ID: 2182853 [TBL] [Abstract][Full Text] [Related]
37. Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis. Pugh MC; Pugh CB Clin Pharm; 1987 Jun; 6(6):475-91. PubMed ID: 3319362 [TBL] [Abstract][Full Text] [Related]
38. The role of therapeutic plasmapheresis in the rheumatic diseases. Jones JV; Clough JD; Klinenberg JR; Davis P J Lab Clin Med; 1981 May; 97(5):589-98. PubMed ID: 6452484 [No Abstract] [Full Text] [Related]
39. [Brief note on the use of cinmetacin in the treatment of rheumatic diseases]. Viara M Clin Ter; 1977 Jun; 81(6):555-66. PubMed ID: 301808 [No Abstract] [Full Text] [Related]